Skip to content
2000
Volume 22, Issue 2
  • ISSN: 1573-3947
  • E-ISSN: 1875-6301

Abstract

In the ongoing fight against cancer, conventional approaches often prove inadequate, struggling with inefficiency and hazardous side effects. Introducing nanochip technology, a promising solution in the pursuit of safer and more efficient cancer treatment. This study examines the development, uses, and potential future of nanochip technology, with a specific focus on its applications in the field of cancer detection and therapy. This review aims to study the current advancements in nanochip technology and its applications in oncology, focusing on how these innovations can potentially revolutionize cancer therapy. To discuss the potential challenges and future prospects of integrating nanochips into clinical oncology practice. Silicon wafers and biocompatible polymers (., PDMS) are commonly used as substrates due to their excellent thermal and electrical properties, ease of fabrication, and ability to integrate with biological systems. Photolithography technique is widely used to pattern nanochips with microscale precision, enabling the fabrication of high-density arrays for biomolecule capture and analysis. Nanochips outperform standard cancer detection and treatment, according to the findings. Nanochips accurately identify cancer biomarkers, enabling early diagnosis and real-time disease progression tracking. Nanochips also carry anti-cancer medications directly to cells, reducing side effects and boosting treatment results. Oncology is advancing using nanochip technology that combines diagnostic and therapeutic functions. These technologies will improve with continued study, bringing the medical community closer to more effective and safer cancer therapies. Nanochips might revolutionize cancer treatment and patient quality of life.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cctr/10.2174/0115733947343855241230115820
2025-01-17
2026-03-11

  • From This Site

    /content/journals/cctr/10.2174/0115733947343855241230115820
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. ZewdieE.T. TessemaA.W. SimegnG.L. Classification of breast cancer types, sub-types and grade from histopathological images using deep learning technique.Heal. Technol.20211161277129010.1007/s12553‑021‑00592‑0
     [Google Scholar]
  2. SohK.P. SzczurekE. SakoparnigT. BeerenwinkelN. Predicting cancer type from tumour DNA signatures.Genome Med.20179110410.1186/s13073‑017‑0493‑229183400
     [Google Scholar]
  3. SuzukiK. IgataH. AbeM. YamamotoY. Multiple cancer type classification by small RNA expression profiles with plasma samples from multiple facilities.Cancer Sci.202211362144216610.1111/cas.1530935218669
     [Google Scholar]
  4. National cancer institute, “common cancer types,”.Natl. Cancer Inst.2013Available from: https://www.cdc.gov/cancer/risk_factors.htm
    [Google Scholar]
  5. PulumatiA. PulumatiA. DwarakanathB.S. VermaA. PapineniR.V.L. Technological advancements in cancer diagnostics: Improvements and limitations.Cancer Rep.202362e176410.1002/cnr2.176436607830
     [Google Scholar]
  6. DickensE. AhmedS. Principles of cancer treatment by chemotherapy.SurgeryElsevier201836313413810.1016/j.mpsur.2017.12.002
     [Google Scholar]
  7. RehmanM. AhmadU. WaseemM. AliB. TariqM.I. Effects of exercise training in patients with lung cancer during chemotherapy treatment.Malays. J. Med. Sci.202330214115210.21315/mjms2023.30.2.1337102045
     [Google Scholar]
  8. LiuZ. RenY. WengS. XuH. LiL. HanX. A new trend in cancer treatment: The combination of epigenetics and immunotherapy.Front. Immunol.20221380976110.3389/fimmu.2022.80976135140720
     [Google Scholar]
  9. OrrantiaA. TerrénI. Astarloa-PandoG. ZenarruzabeitiaO. BorregoF. Human NK cells in autologous hematopoietic stem cell transplantation for cancer treatment.Cancers2021137158910.3390/cancers1307158933808201
     [Google Scholar]
  10. KongX. GaoP. WangJ. FangY. HwangK.C. Advances of medical nanorobots for future cancer treatments.J. Hematol. Oncol.20231617410.1186/s13045‑023‑01463‑z37452423
     [Google Scholar]
  11. PavelićK. Kraljević PavelićS.K. BulogA. AgajA. RojnićB. ČolićM. TrivanovićD. Nanoparticles in medicine: Current status in cancer treatment.Int. J. Mol. Sci.202324161282710.3390/ijms24161282737629007
     [Google Scholar]
  12. SalamaL. PastorE. StoneT. MousaS. Emerging nanopharmaceuticals and nanonutraceuticals in cancer management.Biomedicines20208934710.3390/biomedicines809034732932737
     [Google Scholar]
  13. ZhangM. LiuE. CuiY. HuangY. Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer.Cancer Biol. Med.201714321222710.20892/j.issn.2095‑3941.2017.005428884039
     [Google Scholar]
  14. DhawanU. WangS.M. ChuY.H. HuangG.S. LinY.R. HungY.C. ChenW.L. Nanochips of tantalum oxide nanodots as artificial-microenvironments for monitoring ovarian cancer progressiveness.Sci. Rep.2016613199810.1038/srep3199827534915
     [Google Scholar]
  15. DhawanU. LeeC.H. HuangC.C. ChuY.H. HuangG.S. LinY.R. ChenW.L. Topological control of nitric oxide secretion by tantalum oxide nanodot arrays.J. Nanobiotechnol.20151317910.1186/s12951‑015‑0144‑y26553043
     [Google Scholar]
  16. LeeC.H. ChengY.W. HuangG.S. Topographical control of cell-cell interaction in C6 glioma by nanodot arrays.Nanoscale Res. Lett.20149125010.1186/1556‑276X‑9‑25024917700
     [Google Scholar]
  17. ParkJ. BauerS. SchlegelK.A. NeukamF.W. von der MarkK. SchmukiP. TiO2 nanotube surfaces: 15 nm-an optimal length scale of surface topography for cell adhesion and differentiation.Small20095666667110.1002/smll.20080147619235196
     [Google Scholar]
  18. AbbasZ. RehmanS. An overview of cancer treatment modalities.NeoplasmInTech2018587610.5772/intechopen.76558
     [Google Scholar]
  19. ArrueboM. VilaboaN. Sáez-GutierrezB. LambeaJ. TresA. ValladaresM. González-FernándezÁ. Assessment of the evolution of cancer treatment therapies.Cancers2011333279333010.3390/cancers303327924212956
     [Google Scholar]
  20. CharmsazS. CollinsD.M. PerryA.S. PrencipeM. Novel strategies for cancer treatment: Highlights from the 55th IACR annual conference.Cancers2019118112510.3390/cancers1108112531394729
     [Google Scholar]
  21. MosesM.A. BremH. LangerR. Advancing the field of drug delivery.Cancer Cell20034533734110.1016/S1535‑6108(03)00276‑914667500
     [Google Scholar]
  22. HongJ.A. BrechbielM. BuchsbaumJ. CanariaC.A. ColemanC.N. EscorciaF.E. EspeyM. KunosC. LinF. NarayananD. CapalaJ. National Cancer Institute support for targeted alpha-emitter therapy.Eur. J. Nucl. Med. Mol. Imaging2021491647210.1007/s00259‑021‑05503‑z34378064
     [Google Scholar]
  23. MondalJ. PanigrahiA.K. Khuda-BukhshA.R Conventional chemotherapy: Problems and scope for combined therapies with certain herbal products and dietary supplements.J. Mol. Cell Biol.20141110
     [Google Scholar]
  24. SainiR. SainiS. SharmaS. Nanotechnology: The future medicine.J. Cutan. Aesthet. Surg.201031323310.4103/0974‑2077.6330120606992
     [Google Scholar]
  25. IdrisD.S. RoyA. Synthesis of bimetallic nanoparticles and applications: an updated review.Crystals202313463710.3390/cryst13040637
     [Google Scholar]
  26. MasubuchiT. EndoM. IizukaR. IguchiA. YoonD.H. SekiguchiT. QiH. IinumaR. MiyazonoY. ShojiS. FunatsuT. SugiyamaH. HaradaY. UedaT. TadakumaH. Construction of integrated gene logic-chip.Nat. Nanotechnol.2018131093394010.1038/s41565‑018‑0202‑330038365
     [Google Scholar]
  27. AdhikariJ. RizwanM. DennanyL. AhmedM. U. Electrochemiluminescence nanoimmunosensor for CD63 protein using a carbon nanochips/iron oxide/nafion-nanocomposite modified mesoporous carbon interface.Measurement202117010875510.1016/j.measurement.2020.108755
     [Google Scholar]
  28. LvY. ChenH. WangQ. LiX. XieC. SongZ. Post-silicon nano-electronic device and its application in brain-inspired chips.Front. Neurorobot.20221694838610.3389/fnbot.2022.94838635966373
     [Google Scholar]
  29. SchulzM. ProbstS. CalabreseS. R HomannA. BorstN. WeissM. von StettenF. ZengerleR. PaustN. Versatile tool for droplet generation in standard reaction tubes by centrifugal step emulsification.Molecules2020258191410.3390/molecules2508191432326221
     [Google Scholar]
  30. TaberletP. GriffinS. GoossensB. QuestiauS. ManceauV. EscaravageN. WaitsL.P. BouvetJ. Reliable genotyping of samples with very low DNA quantities using PCR.Nucleic Acids Res.199624163189319410.1093/nar/24.16.31898774899
     [Google Scholar]
  31. MalikS. MuhammadK. WaheedY. Nanotechnology: A revolution in modern industry.Molecules202328266110.3390/molecules2802066136677717
     [Google Scholar]
  32. SilvaG.A. Introduction to nanotechnology and its applications to medicine.Surg. Neurol.200461321622010.1016/j.surneu.2003.09.03614984987
     [Google Scholar]
  33. KhoperiaT.N. MamniashviliG. KhoperiaN. ZedginidzeT.I. ChavchanidzeD. Competitive methods for fabrication of nanochips and replacement of Au, Ag and Pd with nonprecious metals. 216th ECS Trans.20102541496410.1149/1.3422499
     [Google Scholar]
  34. CarvalhoV.M. TeixeiraS. RibeiroJ.E. Editorial for the special issue on micro/nanofluidic and lab-on-a-chip devices for biomedical applications.Micromachines202313171810.3390/books978‑3‑0365‑6099‑1
     [Google Scholar]
  35. PrakashS. PintiM. BhushanB. Theory, fabrication and applications of microfluidic and nanofluidic biosensors.Philos. Trans.- Royal Soc., Math. Phys. Eng. Sci.201237019672269230310.1098/rsta.2011.049822509059
     [Google Scholar]
  36. LeeJ. LeeJ. KimM. Multiscale micro-/nanofluidic devices incorporating self-assembled particle membranes for bioanalysis: A review.Trends Analyt. Chem.202316011694010.1016/j.trac.2023.116940
     [Google Scholar]
  37. DuanC. WangW. XieQ. Review article: Fabrication of nanofluidic devices.Biomicrofluidics20137202650110.1063/1.479497323573176
     [Google Scholar]
  38. JosephT.M. Al-HazmiH.E. ŚniatałaB. EsmaeiliA. HabibzadehS. Nanoparticles and nanofiltration for wastewater treatment: From polluted to fresh water.Environ. Res.2023238Pt 111711410.1016/j.envres.2023.11711437716387
     [Google Scholar]
  39. XiaD. KuZ. LeeS.C. BrueckS.R.J. Nanostructures and functional materials fabricated by interferometric lithography.Adv. Mater.201123214717910.1002/adma.20100185620976672
     [Google Scholar]
  40. SharmaE. RathiR. MisharwalJ. SinhmarB. KumariS. DalalJ. KumarA. Evolution in lithography techniques: Microlithography to nanolithography.Nanomaterials20221216275410.3390/nano1216275436014619
     [Google Scholar]
  41. ShirzadiE. A PEDOT:PSS-based composite hydrogel as a versatile electrode for wearable microneedle sensing platforms.Adv. Sensor Res.202433230012210.1002/adsr.202300122
     [Google Scholar]
  42. Espadinha-CruzP. GodinaR. RodriguesE.M.G. A review of data mining applications in semiconductor manufacturing.Processes20219230510.3390/pr9020305
     [Google Scholar]
  43. XuY. YangX. WangE. Review: Aptamers in microfluidic chips.Anal. Chim. Acta20106831122010.1016/j.aca.2010.10.00721094377
     [Google Scholar]
  44. WilliamsE.D. AyresR.U. HellerM. The 1.7 kilogram microchip: Energy and material use in the production of semiconductor devices.Environ. Sci. Technol.200236245504551010.1021/es025643o12521182
     [Google Scholar]
  45. TiwariH. RaiN. SinghS. GuptaP. VermaA. SinghA.K. Kajal SalviP. SinghS.K. GautamV. Recent advances in nanomaterials-based targeted drug delivery for preclinical cancer diagnosis and therapeutics.Bioengineering202310776010.3390/bioengineering1007076037508788
     [Google Scholar]
  46. SungY.K. KimS.W. Recent advances in the development of gene delivery systems.Biomater. Res.2019231810.1186/s40824‑019‑0156‑z30915230
     [Google Scholar]
  47. ChenD. LiuX. LuX. TianJ. Nanoparticle drug delivery systems for synergistic delivery of tumor therapy.Front. Pharmacol.202314111199110.3389/fphar.2023.111199136874010
     [Google Scholar]
  48. VaisermanA. KoliadaA. ZayachkivskaA. LushchakO. Nanodelivery of natural antioxidants: an anti-aging perspective.Front. Bioeng. Biotechnol.2020744710.3389/fbioe.2019.0044731998711
     [Google Scholar]
  49. MelimC. MagalhãesM. SantosA.C. CamposE.J. CabralC. Nanoparticles as phytochemical carriers for cancer treatment: News of the last decade.Expert Opin. Drug Deliv.202219217919710.1080/17425247.2022.204159935166619
     [Google Scholar]
  50. DebelaD.T. MuzazuS.G.Y. HeraroK.D. NdalamaM.T. MeseleB.W. HaileD.C. KituiS.K. ManyazewalT. New approaches and procedures for cancer treatment: Current perspectives.SAGE Open Med.202192050312121103436610.1177/2050312121103436634408877
     [Google Scholar]
  51. NezamiN. KhorshidiF. MansurA. HabibollahiP. CamachoJ.C. Primary and metastatic lung cancer: Rationale, indications, and outcomes of thermal ablation.Clin. Lung Cancer202324538940010.1016/j.cllc.2023.03.01237127487
     [Google Scholar]
  52. VeselovV.V. NosyrevA.E. JicsinszkyL. AlyautdinR.N. CravottoG. Targeted delivery methods for anticancer drugs.Cancers202214362210.3390/cancers1403062235158888
     [Google Scholar]
  53. HerdianaY. WathoniN. ShamsuddinS. JoniI.M. MuchtaridiM. Chitosan-based nanoparticles of targeted drug delivery system in breast cancer treatment.Polymers20211311171710.3390/polym1311171734074020
     [Google Scholar]
  54. WangH. HeX. Nanoparticles for targeted drug delivery to cancer stem cells and tumor.Meth. Mol. Biol.20181831596710.1007/978‑1‑4939‑8661‑3_630051425
     [Google Scholar]
  55. ZhaoZ. ZhengL. ChenW. WengW. SongJ. JiJ. Delivery strategies of cancer immunotherapy: recent advances and future perspectives.J. Hematol. Oncol.201912112610.1186/s13045‑019‑0817‑331779642
     [Google Scholar]
  56. LiuL. KshirsagarP.G. GautamS.K. GulatiM. WafaE.I. ChristiansenJ.C. WhiteB.M. MallapragadaS.K. WannemuehlerM.J. KumarS. SolheimJ.C. BatraS.K. SalemA.K. NarasimhanB. JainM. Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies.Theranostics20221231030106010.7150/thno.6480535154473
     [Google Scholar]
  57. ScoreiR.I. PopaR. Boron-containing compounds as preventive and chemotherapeutic agents for cancer.Anticancer. Agents Med. Chem.2012110.2174/18715201079116228919912103
     [Google Scholar]
  58. SenapatiS. MahantaA.K. KumarS. MaitiP. Controlled drug delivery vehicles for cancer treatment and their performance.Signal Transduct. Target. Ther.201831710.1038/s41392‑017‑0004‑329560283
     [Google Scholar]
  59. AnjumS. IshaqueS. FatimaH. FarooqW. HanoC. AbbasiB.H. AnjumI. Emerging applications of nanotechnology in healthcare systems: Grand challenges and perspectives.Pharmaceuticals202114870710.3390/ph1408070734451803
     [Google Scholar]
  60. PoojaM. IrumI. AkhtarH. AbuB. Therapeutic application of nanomaterials in the management of health care: An updated review.Int. J. Med. Nano Res.20229110.23937/2378‑3664.1410037
     [Google Scholar]
  61. Kallambadi SadashivappaP. VenkatachalamR. PothuR. BoddulaR. BanerjeeP. NaikR. RadwanA.B. Al-QahtaniN. Progressive review of functional nanomaterials-based polymer nanocomposites for efficient EMI shielding.J. Compos. Sci.2023727710.3390/jcs7020077
     [Google Scholar]
  62. SetuaS. JaggiM. YallapuMM. Targeted and theranostic applications for nanotechnologies in medicine.Nanotechnol. Preven. Regener. Medi.201732339951110.1016/B978‑0‑323‑48063‑5.00006‑X
     [Google Scholar]
  63. AlrushaidN. KhanF.A. Al-SuhaimiE.A. ElaissariA. Nanotechnology in cancer diagnosis and treatment.Pharmaceutics2023153102510.3390/pharmaceutics1503102536986885
     [Google Scholar]
  64. KamN.W.S. O’ConnellM. WisdomJ.A. DaiH. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction.Proc. Natl. Acad. Sci. USA200510233116001160510.1073/pnas.050268010216087878
     [Google Scholar]
  65. ElimH.I. ZhuY. SowC.H. Length dependence of ultrafast optical nonlinearities in vertically aligned multiwalled carbon nanotube films.J. Phys. Chem. C201612031177331773810.1021/acs.jpcc.6b03651
     [Google Scholar]
  66. GreenE. ZhangY. MinusM. Collagen self-assembly in the presence of nano-carbons: A structure-property relationshipProceedings of the IEEE Annual Northeast Bioengineering Conference, NEBECBoston, MA, USA, 2014, pp. 1-2.10.1109/NEBEC.2014.6972803
     [Google Scholar]
  67. ModiD.P. PatelV.P. PatelR.B. PatelJ.N. BhimaniB.V. ShahR.R. Nanorobots: The emerging tools in medicinal applications: A review.Int. J. Drug Dev. Res.201353105119
     [Google Scholar]
  68. HuX. YuS. YangG. LongW. GuoT. TianJ. LiuM. LiX. ZhangX. WeiY. Facile synthesis of inorganic–organic hybrid fluorescent nanoparticles with AIE feature using hexachlorocyclotriphosphazene as the bridge.J. Mol. Liq.202234511769310.1016/j.molliq.2021.117693
     [Google Scholar]
  69. IschyropoulouM. SabljoK. SchneiderL. NiemeyerC.M. NappJ. FeldmannC. AlvesF. High-load gemcitabine inorganic–organic hybrid nanoparticles as an image-guided tumor-selective drug-delivery system to treat pancreatic cancer.Adv. Mater.20233546230515110.1002/adma.20230515137587542
     [Google Scholar]
  70. NeumeierB.L. KhorenkoM. AlvesF. GoldmannO. NappJ. SchepersU. ReichardtH.M. FeldmannC. Fluorescent inorganic-organic hybrid nanoparticles.Chem. Nano. Mat.201951244510.1002/cnma.201800310
     [Google Scholar]
  71. KhorenkoM. PfeiferJ. NappJ. MeschkovA. AlvesF. SchepersU. FeldmannC. Theranostic inorganic–organic hybrid nanoparticles with a cocktail of chemotherapeutic and cytostatic drugs.J. Mater. Chem. B Mater. Biol. Med.202311163635364910.1039/D3TB00226H37017673
     [Google Scholar]
  72. LiZ. SorokaI.L. TarakinaN.V. SabatinoM.A. MuscolinoE. WaloM. JonssonM. DispenzaC. Inorganic/organic hybrid nanoparticles synthesized in a two-step radiation-driven process.Radiat. Phys. Chem.202219711016610.1016/j.radphyschem.2022.110166
     [Google Scholar]
  73. Montes-CobosE. RingS. FischerH.J. HeckJ. StraußJ. SchwaningerM. ReichardtS.D. FeldmannC. LühderF. ReichardtH.M. Targeted delivery of glucocorticoids to macrophages in a mouse model of multiple sclerosis using inorganic-organic hybrid nanoparticles.J. Cont. Rel.201724515716910.1016/j.jconrel.2016.12.00327919626
     [Google Scholar]
  74. ChiH. GuY. XuT. CaoF. Multifunctional organic–inorganic hybrid nanoparticles and nanosheets based on chitosan derivative and layered double hydroxide: cellular uptake mechanism and application for topical ocular drug delivery.Int. J. Nanomedicine2017121607162010.2147/IJN.S12931128280329
     [Google Scholar]
  75. WangL. YanY. A Review of pH-responsive organic–inorganic hybrid nanoparticles for RNAi-based therapeutics.Macromol. Biosci.2021219210018310.1002/mabi.20210018334160896
     [Google Scholar]
  76. MiaoY. YangT. YangS. YangM. MaoC. Protein nanoparticles directed cancer imaging and therapy.Nano Converg.202291210.1186/s40580‑021‑00293‑434997888
     [Google Scholar]
  77. KianfarE. Protein nanoparticles in drug delivery: Animal protein, plant proteins and protein cages, albumin nanoparticles.J. Nanobiotechnol.202119115910.1186/s12951‑021‑00896‑334051806
     [Google Scholar]
  78. HongS. ChoiD.W. KimH.N. ParkC.G. LeeW. ParkH.H. Protein-based nanoparticles as drug delivery systems.Pharmaceutics202012760410.3390/pharmaceutics1207060432610448
     [Google Scholar]
  79. LiuQ. SunY. ChengJ. GuoM. Development of whey protein nanoparticles as carriers to deliver soy isoflavones.Lebensm. Wiss. Technol.202215511295310.1016/j.lwt.2021.112953
     [Google Scholar]
  80. NeekM. KimT.I. WangS.W. Protein-based nanoparticles in cancer vaccine development.Nanomedicine201915116417410.1016/j.nano.2018.09.00430291897
     [Google Scholar]
  81. LohcharoenkalW. WangL. ChenY.C. RojanasakulY. Protein nanoparticles as drug delivery carriers for cancer therapy.BioMed Res. Int.2014201411210.1155/2014/18054924772414
     [Google Scholar]
  82. LiuQ. SunY. CuiQ. ChengJ. KillpartrikA. KempA.H. GuoM. Characterization, antioxidant capacity, and bioaccessibility of Coenzyme Q10 loaded whey protein nanoparticles.Lebensm. Wiss. Technol.202216011325810.1016/j.lwt.2022.113258
     [Google Scholar]
  83. JhaA. NikamA.N. KulkarniS. MutalikS.P. PandeyA. HegdeM. RaoB.S.S. MutalikS. Biomimetic nanoarchitecturing: A disguised attack on cancer cells.J. Cont. Rel.202132941343310.1016/j.jconrel.2020.12.00533301837
     [Google Scholar]
  84. NakamuraT. HarashimaH. Dawn of lipid nanoparticles in lymph node targeting: Potential in cancer immunotherapy.Adv. Drug Deliv. Rev.2020167788810.1016/j.addr.2020.06.00332512027
     [Google Scholar]
  85. KularatneR.N. CristR.M. SternS.T. The future of tissue-targeted lipid nanoparticle-mediated nucleic acid delivery.Pharmaceuticals202215789710.3390/ph1507089735890195
     [Google Scholar]
  86. MendonçaM.C.P. KontA. KowalskiP.S. O’DriscollC.M. Design of lipid-based nanoparticles for delivery of therapeutic nucleic acids.Drug Discov. Today202328310350510.1016/j.drudis.2023.10350536708760
     [Google Scholar]
  87. ZhangC. MaY. ZhangJ. KuoJ.C.T. ZhangZ. XieH. ZhuJ. LiuT. Modification of lipid-based nanoparticles: An efficient delivery system for nucleic acid-based immunotherapy.Molecules2022276194310.3390/molecules2706194335335310
     [Google Scholar]
  88. NiculescuA.G. BîrcăA.C. GrumezescuA.M. New applications of lipid and polymer-based nanoparticles for nucleic acids delivery.Pharmaceutics20211312205310.3390/pharmaceutics1312205334959335
     [Google Scholar]
  89. LiY. YeZ. YangH. XuQ. Tailoring combinatorial lipid nanoparticles for intracellular delivery of nucleic acids, proteins, and drugs.Acta Pharm. Sin. B20221262624263910.1016/j.apsb.2022.04.01335755280
     [Google Scholar]
  90. XuS. IlyasI. LittleP.J. LiH. KamatoD. ZhengX. LuoS. LiZ. LiuP. HanJ. HardingI.C. EbongE.E. CameronS.J. StewartA.G. WengJ. Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: From mechanism to pharmacotherapies.Pharmacol. Rev.202173392496710.1124/pharmrev.120.00009634088867
     [Google Scholar]
  91. GhezziM. PescinaS. PadulaC. SantiP. Del FaveroE. CantùL. NicoliS. Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions.J. Cont. Rel.202133231233610.1016/j.jconrel.2021.02.03133652113
     [Google Scholar]
  92. JinG.W. RejinoldN.S. ChoyJ.H. Multifunctional Polymeric Micelles for Cancer Therapy.Polymers20221422483910.3390/polym1422483936432965
     [Google Scholar]
  93. KottaS. AldawsariH. M. Badr-EldinS. M. NairA. B. Progress in polymeric micelles for drug delivery applications.Pharmaceutics2022148163610.3390/pharmaceutics1408163636015262
     [Google Scholar]
  94. MajumderN. G DasN. DasS.K. Polymeric micelles for anticancer drug delivery.Ther. Deliv.2020111061363510.4155/tde‑2020‑000832933425
     [Google Scholar]
  95. ChaudhuriA. RameshK. KumarD.N. DehariD. SinghS. KumarD. AgrawalA.K. Polymeric micelles: A novel drug delivery system for the treatment of breast cancer.J. Drug Deliv. Sci. Technol.20227710388610.1016/j.jddst.2022.103886
     [Google Scholar]
  96. AliabadiH.M. LavasanifarA. Polymeric micelles for drug delivery.Expert Opin. Drug Deliv.20063113916210.1517/17425247.3.1.13916370946
     [Google Scholar]
  97. DeshmukhA.S. ChauhanP.N. NoolviM.N. ChaturvediK. GangulyK. ShuklaS.S. NadagoudaM.N. AminabhaviT.M. Polymeric micelles: Basic research to clinical practice.Int. J. Pharm.2017532124926810.1016/j.ijpharm.2017.09.00528882486
     [Google Scholar]
  98. IranpourS. BahramiA.R. NekooeiS. Sh SaljooghiA. MatinM.M. Improving anti-cancer drug delivery performance of magnetic mesoporous silica nanocarriers for more efficient colorectal cancer therapy.J. Nanobiotechnol.202119131410.1186/s12951‑021‑01056‑334641857
     [Google Scholar]
  99. AttiaN.F. Abd El-MonaemEM. El-AqapaHG. Iron oxide nanoparticles and their pharmaceutical applications.Appl. Surf. Sci. Adv.20221110028410.1016/j.apsadv.2022.100284
     [Google Scholar]
  100. Bustamante-TorresM. Romero-FierroD. Estrella-NuñezJ. Arcentales-VeraB. Chichande-ProañoE. BucioE. Polymeric composite of magnetite iron oxide nanoparticles and their application in biomedicine: A review.Polymers202214475210.3390/polym1404075235215665
     [Google Scholar]
  101. SoetaertF. KorangathP. SerantesD. FieringS. IvkovR. Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies.Adv. Drug Deliv. Rev.2020163-164658310.1016/j.addr.2020.06.02532603814
     [Google Scholar]
  102. DeviH.S. BodaM.A. ShahM.A. ParveenS. WaniA.H. Green synthesis of iron oxide nanoparticles using Platanus orientalis leaf extract for antifungal activity.Green Process. Synth.20198384510.1515/gps‑2017‑0145
     [Google Scholar]
  103. Fernández-BarahonaI. Muñoz-HernandoM. Ruiz-CabelloJ. HerranzF. PellicoJ. Iron oxide nanoparticles: An alternative for positive contrast in magnetic resonance imaging.Inorganics2020842810.3390/inorganics8040028
     [Google Scholar]
  104. SiddiqiK.S. ur RahmanA. Tajuddin HusenA. Biogenic fabrication of iron/iron oxide nanoparticles and their application.Nanoscale Res. Lett.201611149810.1186/s11671‑016‑1714‑027837567
     [Google Scholar]
  105. SchwamingerS. SyhrC. BerensmeierS. Controlled synthesis of magnetic iron oxide nanoparticles: Magnetite or maghemite?Crystals202010321410.3390/cryst10030214
     [Google Scholar]
  106. KumarA. SinghK.R.B. GhateM.D. LalhlenmawiaH. KumarD. SinghJ. Bioinspired quantum dots for cancer therapy: A mini-review.Mater. Lett.202231313174210.1016/j.matlet.2022.131742
     [Google Scholar]
  107. M WaysT.M. NgK.W. LauW.M. KhutoryanskiyV.V. Silica nanoparticles in transmucosal drug delivery.Pharmaceutics202012875110.3390/pharmaceutics1208075132785148
     [Google Scholar]
  108. WatermannA. BriegerJ. Mesoporous silica nanoparticles as drug delivery vehicles in cancer.Nanomaterials20177718910.3390/nano707018928737672
     [Google Scholar]
  109. ChangD. GaoY. WangL. LiuG. ChenY. WangT. TaoW. MeiL. HuangL. ZengX. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.J. Colloid Interface Sci.201646327928710.1016/j.jcis.2015.11.00126550786
     [Google Scholar]
  110. PelazB. AlexiouC. Alvarez-PueblaR.A. AlvesF. AndrewsA.M. AshrafS. BaloghL.P. BalleriniL. BestettiA. BrendelC. BosiS. CarrilM. ChanW.C.W. ChenC. ChenX. ChenX. ChengZ. CuiD. DuJ. DullinC. EscuderoA. FeliuN. GaoM. GeorgeM. GogotsiY. GrünwellerA. GuZ. HalasN.J. HamppN. HartmannR.K. HersamM.C. HunzikerP. JianJ. JiangX. JungebluthP. KadhiresanP. KataokaK. KhademhosseiniA. KopečekJ. KotovN.A. KrugH.F. LeeD.S. LehrC.M. LeongK.W. LiangX.J. Ling LimM. Liz-MarzánL.M. MaX. MacchiariniP. MengH. MöhwaldH. MulvaneyP. NelA.E. NieS. NordlanderP. OkanoT. OliveiraJ. ParkT.H. PennerR.M. PratoM. PuntesV. RotelloV.M. SamarakoonA. SchaakR.E. ShenY. SjöqvistS. SkirtachA.G. SolimanM.G. StevensM.M. SungH.W. TangB.Z. TietzeR. UdugamaB.N. VanEppsJ.S. WeilT. WeissP.S. WillnerI. WuY. YangL. YueZ. ZhangQ. ZhangQ. ZhangX.E. ZhaoY. ZhouX. ParakW.J. Diverse applications of nanomedicine.ACS Nano20171132313238110.1021/acsnano.6b0604028290206
     [Google Scholar]
  111. XuanY. WangC. GhatakS. SenC.K. Tissue nanotransfection silicon chip and related electroporation-based technologies for in vivo tissue reprogramming.Nanomaterials202414221710.3390/nano1402021738276735
     [Google Scholar]
  112. BargahiN. GhasemaliS. Jahandar-LashakiS. NazariA. Recent advances for cancer detection and treatment by microfluidic technology, review and update.Biol. Proced. Online2022241510.1186/s12575‑022‑00166‑y35484481
     [Google Scholar]
  113. ValieiA. Aminian-DehkordiJ. MofradM.R.K. Gut-on-a-chip models for dissecting the gut microbiology and physiology.APL Bioeng.20237101150210.1063/5.012654136875738
     [Google Scholar]
  114. DessaleM. MengistuG. MengistH.M. Nanotechnology: A promising approach for cancer diagnosis, therapeutics and theragnosis.Int. J. Nanomedicine2022173735374910.2147/IJN.S37807436051353
     [Google Scholar]
  115. BarretoJ.N. McCulloughK.B. IceL.L. SmithJ.A. Antineoplastic agents and the associated myelosuppressive effects: a review.J. Pharm. Pract.201427544044610.1177/089719001454610825147158
     [Google Scholar]
  116. BellinM. MummeryC.L. The cancer’s gone, but did chemotherapy damage your heart?Nat. Rev. Cardiol.201613738338410.1038/nrcardio.2016.8827226155
     [Google Scholar]
  117. JainA. HariprasadM. G. ShariqueM. RedhwanM. A. M. Chemotherapy-induced peripheral neuropathy.Ind. J. Pharma. Edu. Res.20235724410.5530/ijper.57.2.44
     [Google Scholar]
  118. LeeY.T. TanY.J. OonC.E. Molecular targeted therapy: Treating cancer with specificity.Eur. J. Pharmacol.201883418819610.1016/j.ejphar.2018.07.03430031797
     [Google Scholar]
  119. DeshpandeP. JhaveriA. PattniB. BiswasS. TorchilinV. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.Drug Deliv.201825151753210.1080/10717544.2018.143574729433357
     [Google Scholar]
  120. YossefR. TranE. DenigerD.C. GrosA. PasettoA. ParkhurstM.R. GartnerJ.J. PrickettT.D. CafriG. RobbinsP.F. RosenbergS.A. Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapy.JCI Insight2018319e12246710.1172/jci.insight.12246730282837
     [Google Scholar]
  121. KwakM. HanL. ChenJ.J. FanR. Interfacing inorganic nanowire arrays and living cells for cellular function analysis.Small201511425600561010.1002/smll.20150123626349637
     [Google Scholar]
  122. NovoselovK. S. Nanoparticle imaging. 3D structure of individual nanocrystals in solution by electron microscopyScience2015349624529029510.1126/science.aab134326185247
     [Google Scholar]
  123. LeeH. JeonS. SeoJ.S. GohS.H. HanJ.Y. ChoY. A novel strategy for highly efficient isolation and analysis of circulating tumor-specific cell-free DNA from lung cancer patients using a reusable conducting polymer nanostructure.Biomaterials201610125125710.1016/j.biomaterials.2016.06.00327294542
     [Google Scholar]
  124. NgoH.T. WangH.N. FalesA.M. Vo-DinhT. Plasmonic SERS biosensing nanochips for DNA detection.Anal. Bioanal. Chem.201640871773178110.1007/s00216‑015‑9121‑426547189
     [Google Scholar]
  125. YinX. YangJ. ZhangM. WangX. XuW. PriceC.A.H. HuangL. LiuW. SuH. WangW. ChenH. HouG. WalkerM. ZhouY. ShenZ. LiuJ. QianK. DiW. Serum metabolic fingerprints on bowl-shaped submicroreactor chip for chemotherapy monitoring.ACS Nano20221622852286510.1021/acsnano.1c0986435099942
     [Google Scholar]
  126. YadavS. SenapatiS. KumarS. GahlautS.K. SinghJ.P. GLAD based advanced nanostructures for diversified biosensing applications: recent progress.Biosensors20221212111510.3390/bios1212111536551082
     [Google Scholar]
  127. DalalV. BiswasS. Nanoscience: Convergence with biomedical and biological applications.Functional BionanomaterialsSpringerCham202012510.1007/978‑3‑030‑41464‑1_1
     [Google Scholar]
  128. YueM. LiC. WuQ. MaZ. XuH. PalakaS. A facile synthesis of anisotropic SmCo5 nanochips with high magnetic performance.Chem. Eng. J.20183431710.1016/j.cej.2018.02.060
     [Google Scholar]
  129. LiZ. PengW. ZhouJ. ShuiS. LiuY. LiT. ZhanX. ChenY. LanF. YingB. WuY. Multidimensional interactive cascading nanochips for detection of multiple liver diseases via precise metabolite profiling.Adv. Mater.20243621231279910.1002/adma.20231279938263756
     [Google Scholar]
  130. YuanJ. DuanR. YangH. LuoX. XiM. Detection of serum human epididymis secretory protein 4 in patients with ovarian cancer using a label-free biosensor based on localized surface plasmon resonance.Int. J. Nanomedicine201272921292810.2147/IJN.S3264122745553
     [Google Scholar]
  131. SehgalN. GN. KumariA. Latest developments and applications of nanotechnology in agriculture sector: A review.Agric. Rev.20211217510.18805/ag.R‑2175
     [Google Scholar]
  132. McRaeM.P. SimmonsG. WongJ. McDevittJ.T. Programmable bio-nanochip platform: A point-of-care biosensor system with the capacity to learn.Acc. Chem. Res.20164971359136810.1021/acs.accounts.6b0011227380817
     [Google Scholar]
  133. IvanovY.D. GoldaevaK.V. MalsagovaK.A. PleshakovaT.O. GaliullinR.A. PopovV.P. KushlinskiiN.E. AlferovA.A. EnikeevD.V. PotoldykovaN.V. ArchakovA.I. Nanoribbon biosensor in the detection of miRNAs associated with colorectal cancer.Micromachines20211212158110.3390/mi1212158134945431
     [Google Scholar]
/content/journals/cctr/10.2174/0115733947343855241230115820
Loading
Nanochips in the Field of Oncology: Advancements and Potential for Enhanced Cancer Therapy
Curr Cancer Ther Rev 22, 150 (2026); https://doi.org/10.2174/0115733947343855241230115820
/content/journals/cctr/10.2174/0115733947343855241230115820
/content/journals/cctr/10.2174/0115733947343855241230115820
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): biocompatible polymers; Cancer; cancer detection and treatment; future directions; nanochip technology; unregulated proliferation

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test